|
MechanismMmpL3 inhibitors |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Istituto Pasteur-Fondazione Cenci Bolognetti
0 Patents (Medical) associated with Istituto Pasteur-Fondazione Cenci Bolognetti
100 Deals associated with Istituto Pasteur-Fondazione Cenci Bolognetti
100 Translational Medicine associated with Istituto Pasteur-Fondazione Cenci Bolognetti